Jacob Ellison
LifeMDAbout Jacob Ellison
Jacob Ellison is LifeMD’s Chief Analytics Officer, appointed on July 31, 2025. He oversees the company’s data strategy, AI innovation, and FP&A, moving up from Vice President of Analytics based on demonstrated impact linking data insights to patient outcomes and business value .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| LifeMD | Vice President of Analytics | Prior to 2025 → 2025 | Recognized for translating analytics into operational and patient-impact value; promotion tied to expanding oversight of data, AI, and FP&A |
External Roles
- None disclosed in LifeMD’s public filings reviewed for this period.
Investment Implications
- Elevation to Chief Analytics Officer signals a push to institutionalize data-driven operating discipline; his portfolio spans monetization analytics (FP&A), AI productization, and platform data strategy—areas that directly affect CAC, retention, and margin quality in telehealth and pharmacy operations .
- Near-term compensation, ownership, and contract transparency are limited for this executive (not named among NEOs in the latest proxy excerpts surfaced), constraining pay-for-performance assessment and insider-selling pressure analysis; monitor upcoming proxies and any Form 4 activity to gauge alignment and retention risk .